ICPOI2027

ICPOI2027 – Moving Towards Future of Cancer Treatment through Precision Oncology & Immuno-Oncology

International Conference on Precision Oncology and Immuno-Oncology is to be held on August 23-24, 2027 in Edinburgh, United Kingdom during which oncology scientists all over the world will meet in one place during the era of great advances in cancer treatment and research. This event will become an international forum for scientists, oncologists, healthcare professionals, genomics specialists, biomedical professionals and other stakeholders where they could exchange knowledge, share innovative research and collaborate scientifically.

ICPOI2027 will focus on the latest advances in Precision Oncology, Immuno-Oncology, and Precision Medicine, including cancer research, molecular profiling, targeted therapies, biomarkers, cancer immunotherapy, and personalized cancer treatment. The conference will provide professionals with opportunities to share research, network, and explore innovative approaches to improve patient care. Held in Edinburgh, UK, ICPOI2027 will bring together experts to foster collaboration and advance the future of precision-based cancer diagnosis and treatment.

Join us and be part of the global scientific community working toward the next generation of breakthroughs in Precision Oncology and Immuno-Oncology.

Associate Professor Dr. Thomas Böldicke is senior scientist at the Helmholtz Centre for Infection Research (HZI, former GBF) and project leader Cancer Immunotherapy. He developed recombinant antibodies against tumor antigens, particularly against tumor angiogenesis, rhabdyomyosarcoma and recently against TLR2 and TLR9 in pancreatic cancer. He has a collaboration with Prof. Waaga Gasser in Harvard, Medical School about adaptive T-cell therapies. Over 10 years he gave lectures at the Technical University in Braunschweig about immunology, cancer development and immunotherapies. He is in the editorial board of the journal Antibodies as academic editor and co-editor and academic editor in Frontiers in Immunology.